Expert opinion on biological therapy
Reply to: reframing guselkumab's benefit in ulcerative colitis: insights from QUASAR and emerging evidence.
Sheila A Doggrell
Published: 202510.1080/14712598.2025.2592653
No abstract available for this study.
Sheila A Doggrell
No abstract available for this study.